13316-08-0 Usage
Uses
Used in Pharmaceutical Industry:
5-chloro-[1,3]thiazolo[5,4-d]pyrimidine is used as a key intermediate in the synthesis of a range of pharmaceuticals, including antiviral agents and antibiotics. Its presence in these compounds is crucial for their therapeutic efficacy, as it can influence the pharmacokinetics and pharmacodynamics of the final drug products.
Used in Agrochemical Production:
In the agrochemical industry, 5-chloro-[1,3]thiazolo[5,4-d]pyrimidine serves as an intermediate for the development of various agrochemicals. Its incorporation into these products can enhance their effectiveness in controlling pests and diseases in agricultural settings.
Used in Dye Manufacturing:
5-chloro-[1,3]thiazolo[5,4-d]pyrimidine is also utilized in the production of dyes, where its unique chemical structure contributes to the color and stability of the resulting dyes, making them suitable for various applications in textiles, plastics, and other industries.
Used in Medicinal Chemistry and Drug Discovery:
5-chloro-[1,3]thiazolo[5,4-d]pyrimidine holds promise in medicinal chemistry and drug discovery due to its potential to be modified and functionalized to create new derivatives with different biological activities. The chlorine atom in its structure allows for the synthesis of a variety of derivatives, expanding the scope of its applications in the development of novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 13316-08-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,3,1 and 6 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 13316-08:
(7*1)+(6*3)+(5*3)+(4*1)+(3*6)+(2*0)+(1*8)=70
70 % 10 = 0
So 13316-08-0 is a valid CAS Registry Number.
13316-08-0Relevant academic research and scientific papers
N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
-
Page/Page column 89, (2010/12/29)
The present invention relates to N-(hetero)aryl-pyrrolidine derivatives of Formula I: which are JAK inhibitors, such as selective JAK1 inhibitors, useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.
